These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6433503)

  • 1. Effect of chlorpropamide and gliclazide on plasminogen activator activity in vascular walls in patients with maturity onset diabetes.
    Almér LO
    Thromb Res; 1984 Jul; 35(1):19-25. PubMed ID: 6433503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular fibrinolytic activity in long term treatment with second generation sulfonylurea compounds.
    Almér LO
    Acta Endocrinol Suppl (Copenh); 1980; 239():53-5. PubMed ID: 6159764
    [No Abstract]   [Full Text] [Related]  

  • 3. Rise of plasma t-PA fibrinolytic activity in a group of maturity onset diabetic patients shifted from a first generation (tolbutamide) to a second generation sulphonylurea (gliclazide).
    Gram J; Kold A; Jespersen J
    J Intern Med; 1989 Apr; 225(4):241-7. PubMed ID: 2498455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased fibrinolytic potential induced by gliclazide in types I and II diabetic patients.
    Gram J; Jespersen J
    Am J Med; 1991 Jun; 90(6A):62S-66S. PubMed ID: 1908183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of diabetic control in type 2 (non-insulin dependent) diabetic patients treated with different sulphonylureas.
    Harrower AD
    Curr Med Res Opin; 1985; 9(10):676-80. PubMed ID: 3935376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New oral hypoglycemic drug--gliclazide--in the treatment of maturity onset diabetes mellitus.
    Patel JC; Vikani AV
    Indian J Med Sci; 1988 Mar; 42(3):53-9. PubMed ID: 3410515
    [No Abstract]   [Full Text] [Related]  

  • 7. Gliclazide alcohol flush.
    Conget JI; Vendrell J; Esmatjes E; Halperin I
    Diabetes Care; 1989 Jan; 12(1):44. PubMed ID: 2714170
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of gliclazide on non-insulin dependent diabetes mellitus.
    Wajchenberg BJ; Santomaruo AT; Cherem JJ; Malerbi DA; Giurno Filho A; Lerario AC; Giannella Neto D
    Adv Exp Med Biol; 1988; 246():313-9. PubMed ID: 3074661
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of long-term therapy with sulfanylurea preparations on the relation of insulin secretion and the insulin-binding capacity of its receptors].
    Balabolkin MI; Nedosugova LV
    Ter Arkh; 1988; 60(12):91-6. PubMed ID: 3150136
    [No Abstract]   [Full Text] [Related]  

  • 10. Hemobiological properties of gliclazide.
    Ziegler O; Drouin P
    J Diabetes Complications; 1994; 8(4):235-9. PubMed ID: 7833500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolytic capacity following stimulation with desmopressin acetate in patients with diabetes mellitus.
    Grant MB; Fitzgerald C; Guay C; Lottenberg R
    Metabolism; 1989 Sep; 38(9):901-7. PubMed ID: 2505017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolic effects of gliclazide in diabetes type II patients. Study with indirect calorimetry].
    Golay A; Broquet C; Chabot V; Studer S; Felber JP
    Schweiz Med Wochenschr; 1984 Feb; 114(8):261-4. PubMed ID: 6369531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preliminary report on 30 cases of non-insulin-dependent diabetes (NIDD) treated with gliclazide].
    Pan CY
    Zhonghua Nei Ke Za Zhi; 1983 Jul; 22(7):426-8. PubMed ID: 6641388
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of an oral antidiabetic drug on the fibrinolytic system of blood in insulin-treated diabetic patients.
    Gram J; Jespersen J; Kold A
    Metabolism; 1988 Oct; 37(10):937-43. PubMed ID: 3050364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gliclazide: a new sulphonylurea.
    Sullivan JT; Smith RB
    N Z Med J; 1984 Jan; 97(747):22-3. PubMed ID: 6361631
    [No Abstract]   [Full Text] [Related]  

  • 16. [Macroangiopathy and type 2 diabetes mellitus: significance of Diamicron].
    Lesobre B
    Journ Annu Diabetol Hotel Dieu; 1990; ():325-34. PubMed ID: 2195215
    [No Abstract]   [Full Text] [Related]  

  • 17. Vascular benefits of gliclazide beyond glycemic control.
    Jennings PE
    Metabolism; 2000 Oct; 49(10 Suppl 2):17-20. PubMed ID: 11078471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma activity of the enzyme N-acetil-beta-glucosaminidase in healthy and diabetic subjects: effects of treatment with a sulfonylurea drug.
    Giraudo JR; Fugante M; Blaque Quadri J; Reyes G; Duran Saucedo N
    Adv Exp Med Biol; 1988; 246():321-7. PubMed ID: 3250260
    [No Abstract]   [Full Text] [Related]  

  • 19. Free radical scavenging activity of sulfonylureas: a clinical assessment of the effect of gliclazide.
    Jennings PE; Belch JJ
    Metabolism; 2000 Feb; 49(2 Suppl 1):23-6. PubMed ID: 10693916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of short term hypoglycemic treatment with gliclazide and gliquidone on platelet function in patients with diabetes mellitus type II].
    Grzeszczak W; Strojek K
    Pol Tyg Lek; 1993 Apr; 48 Suppl 1():38-9. PubMed ID: 8516206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.